[Analysis of a circulating anticoagulant in the course of treatment with an antivitamin K. Importance in a febrile patient].
Henrionnet
A
A
Béchade
D
D
Algayres
J P
JP
Daly
J P
JP
D000070:Acebutolol / Q000627:therapeutic use; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D017152:Antibodies, Antiphospholipid / Q000097:blood; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004077:Digoxin / Q000627:therapeutic use; D005335:Fever of Unknown Origin / Q000097:blood*; D006801:Humans; D007136:Immunoglobulins / Q000097:blood*; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008297:Male; D010630:Phenindione / Q000031:analogs & derivatives / Q000627:therapeutic use; D011778:Q Fever / Q000097:blood
D000889:Anti-Arrhythmia Agents; D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D007136:Immunoglobulins; D016682:Lupus Coagulation Inhibitor; C019158:circulating anticoagulants; D010630:Phenindione; D000070:Acebutolol; D004077:Digoxin; C017673:fluindione